Pharmaceutical manufacturers of Doxazosin

Dr. Reddy’s Laboratories Ltd. functions as an integrated pharmaceutical firm, dedicated to supplying cost-effective and innovative medications to promote healthier lifestyles. With a focus on Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products, Dr. Reddy’s delivers a range of products and services such as APIs, customized pharmaceutical services, generics, biosimilars, and distinct formulations. The primary therapeutic areas of concentration encompass gastro-intestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy’s has a presence in various global markets, with significant engagements in the USA, Europe, India, Russia, and other CIS nations.

For more than 40 years, Apotex has been a reputable name in the Canadian pharmaceutical industry, offering patients increased availability to high-quality, cost-effective medications

Unichem Laboratories was founded in 1944 by Late Mr. Amrut Mody, a pioneer in the Indian pharmaceuticals business. With a rich tradition of unwavering quality and reliability, Unichem brings together a unique blend of modern, value-added research and deep knowledge of the Indian pharmaceuticals industry.ç

Wockhardt UK (WUK) operates as a diverse pharmaceutical company, serving as a significant provider of healthcare products to the NHS through hospitals, multiple retail pharmacy chains, and wholesalers. It is currently experiencing an exciting period with thriving export and contract manufacturing divisions. Leveraging the global strength, research base, and impressive product pipeline of its parent company, Wockhardt UK is well-positioned for future growth.

FAREVA stands as a prominent global pharmaceutical CDMO with leading expertise in the development and production of a wide variety of Drug Products and Active Pharmaceutical Ingredients (APIs). The company has a workforce of 13,000 individuals spread across 41 manufacturing facilities situated in 13 countries across EMEA and the Americas. Among these facilities, 18 are exclusively dedicated to pharmaceutical operations. FAREVA’s API division carries out its activities in 3 European locations situated in France and Germany.

Dream that drives us at Nosch. The laudable goal that we aim for. The vision that suffuses us with the passion to innovate and excel. Over the past twenty one years, we have been ceaselessly engaged in a quest to sustain and improve the quality of life through creating safe pharmaceutical solutions. Our competencies have grown to embrace the entire pharmaceutical value chain-APIs and semi-finished Formulations. Today, with an impeccable reputation for uncompromising quality and timely delivery, Nosch has emerged as the partner of choice across the world.

Established as Toho Bussan Koeki, LTD. through investment from Nikko Shoji, Ltd. Engaged in a partnership with Permachem Corporation based in Florida, USA, to manufacture and distribute Permachem products in Japan and Southeast Asia. The location of PERMACHEM ASIA LTD. is in Kikugawa, Shizuoka, Japan, and is affiliated with the Other Chemical Product and Preparation Manufacturing Industry, along with 6 other companies within the PERMACHEM ASIA LTD. corporate network.

Nifty Labs Private Limited was established in March 2005. The corporation has specialized in the production of Active Pharmaceutical Ingredients (APIs) and advanced Intermediates for APIs.

Srini Pharmaceuticals Pvt. Ltd., was established in 1995. USFDA, TGA and KFDA approved fully integrated global pharmaceutical company, located just about 60 KM's away from the Pharma Capital of India, Hyderabad. Our manufacturing facility has five fully equipped production blocks with most efficient functional utilities with multiple clean rooms having the ability to produce 10 API's at a time, supported by central quality control laborites with all sophisticated instruments by maintaining complete QMS. The state-of-the-Art Research and development laboratory recognized and approved by Department of Science and Technology, Government of India.

FARMAK, a.s. is a privately held chemical and pharmaceutical company based in the Czech Republic. The company focuses on the research, development, and production of active pharmaceutical ingredients, chemical products, and specialized chemicals.

Cohance Lifesciences stands as a prominent CDMO and API platform, providing a wide range of products and services throughout every stage of a compound's lifespan, from its development to commercialization. Leveraging our expertise in intricate chemical processes, we deliver comprehensive CDMO services to global innovators and have successfully overseen numerous projects from inception to market launch over the years. As a global API participant, we cater to clients in approximately 60 nations, offering 80+ molecules supported by strong research and development, regulatory capabilities, and manufacturing facilities. Committed to excellence, we are one of the leading integrated exporters of pellets and possess formidable development and manufacturing capabilities.

Therapiva is a prominent manufacturer of generic pharmaceuticals with a strong and innovative R&D center and a state-of-the-art API manufacturing plant. It offers a diverse product range spanning various medical areas and is capable of managing novel, intricate, and high-risk reactions. Therapiva provides new chemical entities (NCEs), cGMP intermediates, and key starting materials (KSMs) to global innovators. The company is furnished with adaptable, multi-faceted, and advanced infrastructure, customized to accommodate the production of complex molecular chemistry emerging from Innovator's development pipelines.

Zhejiang Lepu operates as a high-tech enterprise at the state level and a patent demonstration enterprise at the provincial level. It possesses a state-level academician workstation and a provincial research institute. The company has formed collaborative laboratories with well-known universities and research institutions, such as Nankai University, Zhejiang University of Technology, and the China State Institute of Pharmaceutical Industry. Zhejiang Lepu has also enlisted a team of professors and industry experts to enhance the company's research and development capabilities. Zhejiang Pure Pharmaceutical Co. Ltd. is an integrated enterprise specializing in the research and development, production, and sales of steroid hormones APIs and intermediates. The facility strictly adheres to cGMP requirements. The company aims to provide high-quality intermediates and APIs to both domestic and international manufacturers, as well as offer Customer Fabrication Services. Several customers from various countries, including Spain, Japan, and India, have conducted on-site audits at the company's factories and have established long-term business relationships after expressing high satisfaction. Wanbond Pharmaceutical Holding Group Co., Ltd., known as 'the group,' is a pharmaceutical manufacturing listed company on the Shenzhen main board (stock code 002082). Its primary focus is on the large health industry, emphasizing pharmaceutical manufacturing and medical devices. The group's headquarters is situated in Wenling, Taizhou, Zhejiang. The company was honored to be listed among the top 500 private manufacturing enterprises in China in 2020, securing the 341st position. The industrial sector of Wanbond Pharmaceutical Holding Group.

Nivedita Chemicals Pvt. Ltd. is presently an exporter of Active Pharmaceuticals Ingredients (API's) and Intermediates. We have been serving the pharmaceutical industry in India since 1972 and international market since 1987 with quality products. We are committed to help preserve life, and provide innovative yet affordable health care drugs. Anek Prayog Pvt. Ltd. is our sister concern, established by Late. Dr. Vasant Palkar in 1979. Anek Prayog Pvt Ltd. is the only manufacturing site of Nivedita Chemicals Pvt. Ltd. Nivedita Chemicals Pvt. Ltd. also takes care of the financial, marketing and R&D aspects of the business. Our goal is to manufacture vital drugs as import substitutes.